Vitalhub (TSE:VHI) PT Raised to C$8.00

Vitalhub (TSE:VHIFree Report) had its price target increased by Cormark from C$7.50 to C$8.00 in a report issued on Tuesday, BayStreet.CA reports.

Separately, Canaccord Genuity Group raised their price objective on Vitalhub from C$7.50 to C$8.00 and gave the company a buy rating in a research note on Monday, May 13th.

View Our Latest Stock Report on VHI

Vitalhub Trading Up 5.0 %

Shares of Vitalhub stock opened at C$7.81 on Tuesday. The stock has a 50 day moving average of C$6.64 and a 200 day moving average of C$5.58. Vitalhub has a 12 month low of C$2.35 and a 12 month high of C$7.81. The firm has a market cap of C$395.89 million, a PE ratio of 77.50, a PEG ratio of 2.61 and a beta of 1.23.

Vitalhub (TSE:VHIGet Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.07 by C($0.03). The company had revenue of C$15.26 million during the quarter, compared to the consensus estimate of C$14.12 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. As a group, equities research analysts forecast that Vitalhub will post 0.2700115 earnings per share for the current fiscal year.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

See Also

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.